A Study of Baricitinib (LY3009104) in Children and Adolescents With Atopic Dermatitis
Status:
Recruiting
Trial end date:
2027-01-15
Target enrollment:
Participant gender:
Summary
The reason for this study is to see if the study drug called baricitinib works and is safe in
children and teenage participants with atopic dermatitis.